SCHEMBL9169155

SCHEMBL9169155

Nc1c2c(nc3ccccc13)CSC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 8/20 0.58
BCHE P06276 5/20 0.58
ALDH1A1 P00352 5/20 0.58
HSD17B10 Q99714 5/20 0.58
TSHR P16473 4/20 0.58
KDM4E B2RXH2 4/20 0.58
CYP1A2 P05177 2/20 0.58
CYP2D6 P10635 2/20 0.58
CHRM2 P08172 2/20 0.58
ADRA2A P08913 2/20 0.58
ADORA3 P0DMS8 2/20 0.58
CHRM1 P11229 2/20 0.58
SLC6A2 P23975 2/20 0.58
OPRM1 P35372 2/20 0.58
KCNH2 Q12809 2/20 0.58
CACNB4 O00305 1/20 0.58
CACNA1A O00555 1/20 0.58
SLC22A2 O15244 1/20 0.58
SLC22A1 O15245 1/20 0.58
ABCC4 O15439 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9216711 0.85 ACHE (0.62) ACHEBCHEALDH1A1HSD17B10TSHR
SCHEMBL4502500 0.85 ACHE (0.62) ACHEBCHEALDH1A1HSD17B10TSHR
SCHEMBL9737406 0.83 ACHE (0.68) ACHEBCHEALDH1A1HSD17B10TSHR
SCHEMBL9735057 0.83 ACHE (0.68) ACHEBCHEALDH1A1HSD17B10TSHR
SCHEMBL9738344 0.77 ACHE (0.69) ACHEBCHEALDH1A1HSD17B10TSHR
SCHEMBL9168843 0.74 KMT2A (0.61) ACHELMNASMN1; SMN2GAATP53
SCHEMBL9211865 0.74 ACHE (0.62) ACHEBCHEGRIN1GRIN2A
SCHEMBL9171949 0.74 ACHE (0.42) ACHEBCHECHRM1GRIN1GRIN2A
Tacrine SCHEMBL2828 0.74 ACHE (1.00) ACHEBCHEALDH1A1HSD17B10TSHR
SCHEMBL5047992 0.74 ACHE (1.00) ACHEBCHEALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0287977-B1 Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1994-06-29 EP claimed
US-5112830-A Cognition Activators HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-05-12 US claimed
EP-0287977-A2 Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-10-26 EP claimed
US-5389629-A Increase cholinergic function HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-02-14 US disclosed
EP-0287977-B1 Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1994-06-29 EP disclosed
US-5208330-A Cognition activators HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-05-04 US disclosed
US-5206387-A Chemical intermediates for memory enhancing drugs HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-04-27 US disclosed
US-5112830-A Cognition Activators HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-05-12 US disclosed
US-5002955-A Pyrroloquinolines for enhancement of memory HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1991-03-26 US disclosed
US-4843079-A ALZHEIMER*S DISEASE HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-06-27 US disclosed
EP-0287977-A2 Fused heteroalkylene quinolinamines, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-10-26 EP disclosed
EP-0268871-A1 Quinoline derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1988-06-01 EP disclosed